Independent determinants of 4-year combined end-point (mortality, myocardial infarction, stroke or further revascularizations). Odds Ratios (OR) with 95% Confidence Intervals (CI) and probability associated to a two-tailed test (p) estimated by a logistic regression model for survey data
| OR | 95% CI | p Value | |
|---|---|---|---|
| Age (years) | 1.02 | 1.00 to 1.03 | 0.018 |
| Gender (female vs male) | 0.77 | 0.55 to 1.07 | 0.114 |
| Year 2005 vs 2002 | 1.02 | 0.80 to 1.32 | 0.856 |
| PCI vs Medical therapy | 1.09 | 0.82 to 1.45 | 0.543 |
| CABG vs Medical therapy | 0.31 | 0.19 to 0.49 | <0.001 |
| Syntax score 23–32 vs <23 | 1.37 | 0.97 to 1.94 | 0.075 |
| Syntax score ≥33 vs <23 | 2.07 | 1.32 to 3.27 | 0.002 |
| eGFR 30–60 vs >60 | 1.32 | 0.94 to 1.86 | 0.112 |
| eGFR <30 vs >60 | 4.66 | 2.15 to 10.07 | <0.001 |
| LV EF 35–50% vs >50% | 1.28 | 0.94 to 1.74 | 0.120 |
| LV EF <35% vs >50% | 3.53 | 2.09 to 5.96 | <0.001 |
| Diabetes mellitus (yes vs no) | 1.43 | 1.10 to 1.87 | 0.008 |
| NSTEMI/UA vs stable CAD | 1.20 | 0.91 to 1.56 | 0.191 |
| STEMI vs stable CAD | 2.08 | 1.30 to 3.33 | 0.002 |
CABG, coronary artery by-pass surgery; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate in ml/min; LV EF, left ventricukar ejection fraction; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; UA, unstable angina.